Ilinca Prisacaru, MD
Family Medicine · Pell City, ALNPI 1831458892
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 718 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 48 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 718 payments — averaging $13.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$1K
- GSK$1K
- Pfizer$660
- Johnson & Johnson$502
- Lilly USA, LLC$495
- plus $5K from 42 others
What the payments were for
- Food & beverage$9,869100%
- Education$350%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$9,904 in reported general payments places this provider in the 90th percentile of 1,680 family medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 277 | $268,536 |
| MounjaroTirzepatide | 119 | $133,637 |
| EliquisApixaban | 156 | $116,025 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 126 | $89,897 |
| JardianceEmpagliflozin | 74 | $73,155 |
| Tresiba Flextouch U-100Insulin Degludec | 61 | $71,791 |
| Tresiba Flextouch U-200Insulin Degludec | 39 | $50,391 |
| JanuviaSitagliptin Phosphate | 28 | $43,955 |
| LinzessLinaclotide | 70 | $43,160 |
| FarxigaDapagliflozin Propanediol | 43 | $40,309 |
| XareltoRivaroxaban | 52 | $36,546 |
| MyrbetriqMirabegron | 51 | $33,501 |
| TrulicityDulaglutide | 23 | $29,929 |
| RybelsusSemaglutide | 26 | $29,025 |
| ProliaDenosumab | 11 | $19,219 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,243 | $297,561303 claims |
| Lilly USA, LLCMounjaro, Trulicity | $495 | $163,566142 claims |
| PfizerEliquis, Premarin | $660 | $121,319168 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $1,042 | $104,701154 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $409 | $62,24693 claims |
| MerckJanuvia | $32 | $43,95528 claims |
| AbbVieLinzess | $1,165 | $43,16070 claims |
| Johnson & JohnsonXarelto | $502 | $36,54652 claims |
| Astellas Pharma US IncMyrbetriq | $112 | $33,50151 claims |
| AmgenProlia | $363 | $19,21911 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $267 | $8,24015 claims |
| BayerKerendia | $223 | $6,74311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,680 family medicine providers in Alabama.
Other family medicine in Pell City
- Jack VibbertPell City$14K
- Lashelle BarmoreBirmingham$486K
- Regina BenjaminBayou la Batre$222K
- Jonathan ParkerMuscle Shoals$214K
- Kathleen DupperHuntsville$210K
- Whitney TewHuntsville$114K
- Kelly HunterTuscaloosa$84K
- Daniel EnglertHuntsville$82K
- Joel LaughlinMobile$75K
- Ashleigh Butts-WilkersonMobile$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.